Log In
Print
BCIQ
Print
Print this Print this
 

Zalviso (ARX-01) (formerly Sufentanil NanoTab PCA System)

Also known as: Sublingual Sufentanil NanoTabs

  Manage Alerts
Collapse Summary General Information
Company AcelRx Pharmaceuticals Inc.
DescriptionPre-programmed, handheld device that delivers a sublingual formulation of sufentanil, a synthetic opioid analgesic
Molecular Target Opioid receptor (OPR)
Mechanism of ActionOpioid receptor agonist
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentRegistration
Standard IndicationPain
Indication DetailsManage post-operative pain in patients undergoing unilateral knee replacement surgery; Treat moderate to severe acute pain following knee replacement surgery; Treat moderate to severe acute pain in a hospital setting; Treat post-operative pain following major surgery; Treat post-operative pain following total unilateral knee or hip replacement surgery; Treat post-operative pain in patients undergoing major abdominal surgery
Regulatory Designation

Partner

Gruenenthal Group


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today